BostonGene, developer of the leading AI foundation model for cancer and the immune system, announced its participation at the 21st Annual Industry/Academia Precision Oncology & RadMed Symposium, where ...
A technology that combines transcriptomic data and AI enables a novel approach to drug discovery based on the state of cells, ...
Our Bureau, Bengaluru Monday, October 27, 2025, 16:15 Hrs [IST] ...
Flowering Chinese cabbage, a staple leafy vegetable across Asia, has undergone decades of breeding to improve adaptability, ...
In modern functional genomics, understanding how specific genes control cellular behavior requires both targeted intervention and high-resolution analysis. That’s where Perturb-Seq comes in—a method ...
Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...
Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback